A Cutting-Edge Cancer Treatment Is Under FDA Investigation—for Cancer Risk

A Cutting-Edge Cancer Treatment Is Under FDA Investigation—for Cancer Risk

  • Af
  • Episode
      2183
  • Published
      30. nov. 2023
  • Forlag
0 Anmeldelser
0
Episode
2183 of 2361
Længde
7M
Sprog
Engelsk
Format
Kategori
Fakta

CAR-T cell therapy harnesses the immune system to attack blood cancers. Six years after approving the first treatment, the FDA is investigating whether it can give rise to secondary cancers.

Read this story here.

Learn about your ad choices: dovetail.prx.org/ad-choices


Lyt når som helst, hvor som helst

Nyd den ubegrænsede adgang til tusindvis af spændende e- og lydbøger - helt gratis

  • Lyt og læs så meget du har lyst til
  • Opdag et kæmpe bibliotek fyldt med fortællinger
  • Eksklusive titler + Mofibo Originals
  • Opsig når som helst
Prøv nu
DK - Details page - Device banner - 894x1036
Cover for A Cutting-Edge Cancer Treatment Is Under FDA Investigation—for Cancer Risk

Other podcasts you might like ...